Lycopene from two food sources does not affect antioxidant or cholesterol status of middle-aged adults

1475-2891-3-15 1475-2891 Research Lycopene from two food sources does not affect antioxidant or cholesterol status of middle-aged adults Collins JK jcollins-usda@lane-ag.org Arjmandi BH arjmand@okstate.edu Claypool PL plcstat@okstate.edu Perkins-Veazie P pperkins-usda@lane-ag.org Baker RA rbaker11@tampabay.rr.com Clevidence BA Clevideb@ba.ars.usda.gov

USDA, ARS, South Central Agricultural Research Laboratory, Lane, OK, USA

Dept. Nutritional Sciences, Oklahoma State University, Stillwater, OK, USA

Dept. Statistics, Oklahoma State University, Stillwater, OK, USA

Retired, USDA, ARS, Citrus and Subtropical Products Laboratory, Winter Haven, FL, USA

USDA, ARS, Diet and Human Performance Laboratory, Beltsville, MD, USA

Nutrition Journal 1475-2891 2004 3 1 15 http://www.nutritionj.com/content/3/1/15 15369594 10.1186/1475-2891-3-15 13 8 2004 15 9 2004 15 9 2004 2004 Collins et al; licensee BioMed Central Ltd. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Epidemiological studies have reported associations between reduced cardiovascular disease and diets rich in tomato and/or lycopene. Intervention studies have shown that lycopene-containing foods may reduce cholesterol levels and lipid peroxidation, factors implicated in the initiation of cardiovascular disease. The objective of this study was to determine whether consumption of lycopene rich foods conferred cardiovascular protection to middle-aged adults as indicated by plasma lipid concentrations and measures of ex vivo antioxidants.

Methods

Ten healthy men and women consumed a low lycopene diet with no added lycopene (control treatment) or supplemented with watermelon or tomato juice each containing 20 mg lycopene. Subjects consumed each treatment for three weeks in a crossover design. Plasma, collected weekly was analyzed for total cholesterol, high density lipoprotein cholesterol (HDL-C) and triglyceride concentrations and for the antioxidant biomarkers of malondialdehyde formation products (MDA), plasma glutathione peroxidase (GPX) and ferric reducing ability of plasma (FRAP). Data were analyzed using Proc Mixed Procedure and associations between antioxidant and lipid measures were identified by Pearson's product moment correlation analysis.

Results

Compared to the control diet, the lycopene-containing foods did not affect plasma lipid concentrations or antioxidant biomarkers. Women had higher total cholesterol, HDL-C and triglyceride concentrations than did the men. Total cholesterol was positively correlated to MDA and FRAP while HDL-C was positively correlated to MDA and GPX. GPX was negatively correlated to triglyceride concentration.

Conclusions

The inclusion of watermelon or tomato juice containing 20 mg lycopene did not affect plasma lipid concentrations or antioxidant status of healthy subjects. However, plasma cholesterol levels impacted the results of MDA and FRAP antioxidant tests.

Background

Watermelons and tomatoes are good sources of the carotenoid lycopene 12. However, bioavailability of lycopene is not directly related to plant content, and depends in a large part upon plant matrix effects. In tomatoes, heat processing and homogenization breaks protein-carotenoid complexes, releases lycopene from cell wall linkages and improves human uptake of this compound 3456, while heat processing is not necessary for adequate uptake of lycopene from watermelon juice 7. Extracts of both foods exhibit antioxidant activity in vitro and function is attributed to lycopene since isolated lycopene demonstrates strong oxygen and peroxy radical scavenging properties 8910.

Recent epidemiological studies have linked reductions in risks of cardiovascular disease with diets rich in lycopene containing foods. These reductions in risk have been primarily attributed to the antioxidant properties of lycopene 1112. Improved antioxidant parameters of lymphocytes have been reported in clinical trials that supplemented diets with 16.5 mg and 40 mg /day of lycopene from tomato puree and tomato juice, respectively 1314. Other clinical trials have shown reductions in low-density lipoprotein (LDL) oxidation resulting from lycopene supplementation 151617. LDL contains unsaturated fatty acids and can be oxidized by free radicals and peroxidizing agents. Since lycopene is primarily attached to LDL in plasma, it may protect against atherosclerosis through inhibition of lipid peroxidation and foam cell production 1218.

Other studies have assessed response of plasma lipids to lycopene-rich diets. In one study, six healthy men were supplemented with 60 mg/day for three months with tomato lycopene (LycoRed) with a 14% reduction in LDL-C and no change in HDL-C 19. Researchers concluded that lycopene was involved in controlling cholesterol synthesis and found the same results in a macrophage cell study 19. It is not known if other lycopene containing foods can act ex vivo as antioxidants or alter cholesterol levels.

The objectives of this study were to compare the ability of two lycopene containing foods, tomato and watermelon to provide cardiovascular protection to middle-aged adults by measuring changes in cholesterol levels and antioxidant ex vivo biomarkers.

Methods

Experimental Design

Samples for this study came from a larger study, which has been reported in detail 7. This study was a diet-controlled, repeated measures crossover design with ten healthy non-smoking subjects, five men (average age 49 years) and five women (average age 51 years) recruited from the Beltsville, MD area (Table 1). In addition to a base diet, which provided 34% of energy from fat and minimal amounts of lycopene, subjects were randomly assigned to receive three dietary treatments for 3 weeks each: 1) control (no added lycopene); 2) 20.1 mg lycopene per day from watermelon juice; and 3) 18.4 mg lycopene per day from tomato juice. All subjects followed a low-lycopene diet for two weeks before the first treatment and during the four-week washout periods between treatments. Total study duration was 19 weeks. During treatment periods, all meals were prepared and consumed Monday through Friday at the Beltsville Human Nutrition Research Center's Human Studies Facility, and weekend meals were packed for off-site consumption. Blood was drawn from fasted subjects before treatment (the day before the start of study and on the first day of the study), prior to treatment and weekly during treatment. Plasma was separated from whole blood by centrifugation and stored at -80°C until analyzed for cholesterol and antioxidant activity.

Table 1

Description of human clinical study participants.

Gender

Age (Range) yr

BMI (Range) Kg/m²

Men

49 (43–68)

26.3 (23.0–29.5)

Women

51 (35–63)

29.1 (23.5–34.5)

Juice Treatments

Watermelon juice for the study was prepared at a pilot plant at the USDA Citrus and Subtropical Products Laboratory, Winter Haven, FL without heat treatment as previously described 7. Canned commercial tomato juice (Campbell's, Camden, NJ) was used for the tomato intervention. Juices were analyzed for carotenoid content using established extraction procedures with reversed phase HPLC with photo diode array detector (Waters Corp, Franklin, MA) 7. For watermelon treatment, subjects were given one bottle of juice (260 g each) at breakfast, lunch and dinner, which provided daily totals of 20.1 mg lycopene, 0.90 mg phytoene, 0.45 mg phytofluene and 2.5 mg beta carotene. The juice contained 94% trans lycopene and 6% cis isomers, primarily 5-cis and 13-cis with minimal amounts of other cis isomers 7. For tomato juice treatment, subjects were given one serving (122 g each) at breakfast and dinner, which provided daily totals of 18.4 mg lycopene, 2.1 mg phytoene, 1.1 mg phytofluene and 0.6 mg beta carotene with 89% of the lycopene as trans lycopene and 10.8% cis isomers, primarily identified as 5-cis, 9-cis, 13-cis, and 15-cis, and minimal amounts of other cis isomers 7.

Cholesterol Analysis

Plasma samples were thawed on ice for four hours then mixed by vortexing, prior to preparing for assays. Serum total cholesterol and triglyceride concentrations were determined enzymatically using kits from Roche Diagnostics (Sommerville, NJ). Serum HDL-cholesterol was determined by a direct method (Unimate HDL Direct ; Roche Diagnostics, Indianapolis, IN) that utilizes the combined action of polymers, polyanions, and detergent to solubilize cholesterol from HDL but not from VLDL, LDL, and chylomicrons as previously described 20. Analysis was performed on a Cobas-Fara II Clinical Analyzer (Montclair, NJ) using commercially available calibrators and quality control standards (Roche Diagnostics, Indianapolis, IN).

Plasma Glutathione Peroxidase Assay

Plasma from subjects was analyzed for plasma glutathione peroxidase using an ELISA kit (OXIS Internatl., Portland, OR). Two replicates per sample of 20 μl of plasma were diluted 1:25 with TRIS-HCl buffer then pippetted into pre-coated polyclonal antibodies microplate wells specific for human plasma glutathione peroxidase (GPX). The amount of enzyme present was determined by reaction with para-nitrophenyl-phosphate and was read using a microplate reader at 405 nm (Elx 808 Ultra Microplate Reader, Bio-Tek Instruments Inc., Winooski, VT). The concentration of plasma GPX was determined from a standard curve for each plate using five dilutions of GPX standard.

Plasma lipid peroxidation

Malondialdehyde compounds were determined colorimetrically using a commercial kit specific for measuring free and total malondialdehyde compounds (OXIS Internatl., Portland, OR). Two replicates per sample of 210 μl of plasma were added to each test tube with 11 μl of 500 mM butylated hydroxytoluene and 5.3 μl of concentrated hydrochloric acid. Tubes were capped, mixed then incubated at 60°C for 80 minutes, cooled to room temperature and 680 μl of N-methyl-2-phenylindole in acetonitrile was added. Then tubes were mixed, and centrifuged at 13,000 g for 5 minutes. New tubes were prepared and 660 μl of clear supernatant was added with 115 μl of concentrated HCl. Tubes were capped, mixed and incubated at 45°C for 60 minutes. Samples were centrifuged at 13,000 g for 5 min and the supernatant was read on a spectrophometer at 575 nm. Concentration of samples was determined using a five point standard curve.

Ferric reducing ability of plasma assay

This assay was conducted according to previously published methods 1. In brief, three reagents were used: 1) sodium acetate, acetic acid buffer (pH 3.6); 2)10 mmol/L solution of 2, 4,6-tripyridyl-s-triazine in a 40 mmol/L solution of hydrochloric acid (Sigma, St. Louis, MO); and 3) 20 mmol/L solution of ferric chloride hexahydrate prepared in double deionized water. The FRAP reagent was prepared daily with 25 ml of reagent one, 2.5 ml reagent two and three that were heated to 37°C before using 21. The assay was conducted with 10 uL of plasma that was diluted with 30 μl of ddi water. Sample was added to reagent in cuvettes with an autosampler and then read on a COBAS FARA II spectrofluorometric centrifugal analyzer (Roche, Montclair, NJ) at 593 nm at four minutes. FRAP values were determined from a five point curve using a trolox (vitamin E analog) standard. Standard curves were run after every 90 samples.

Experimental procedures for the clinical trial were approved by the Institutional Review Board at the Johns Hopkins University Bloomberg School of Hygiene and Public Health; subjects gave their written informed consent to participate. The plasma cholesterol and antioxidant studies were approved by the Institutional Review Board at Oklahoma State University, Stillwater, OK. Data were analyzed using Proc Mixed Procedure and mean separation was performed using LSMEANS, correlation analysis was performed using Spearman's Correlation Coefficient Analysis (SAS Statistical Analysis Software, version 8.2, SAS Institute, Cary, NC).

Results

Because there were significant four way interactions with gender × intervention period × treatment × weeks with MDA, FRAP, GPX and cholesterol analysis, trends by treatment, intervention period or week of treatment were not seen. Supplementing the diet with 20 mg/day of lycopene of either food did not change the plasma antioxidant status of the subjects and values ranged from 0.66–2.20, 540–1094, and 1296–2596 :mol/L for MDA, FRAP and GPX respectively. These levels are similar to levels reported for healthy subjects in other studie 2223.

Intervention with 20 mg of lycopene to the diet of subjects did not alter their total cholesterol, HDL-C or triglyceride status. However, there were gender differences and the women had higher average levels of plasma triglycerides, total cholesterol and HDL-C than men (Figure 1). The higher cholesterol levels for women compared to men in this study were not unusual since women in this age range often have higher cholesterol levels than men, a phenomenon related to decreased estrogen production 2425. In this study, menopausal information was not recorded.

Figure 1

Mean plasma total cholesterol, triglycerides, and high density lipoprotein (HDL) cholesterol (mg/dl) of 5 men and 5 women supplemented for 3 week with no lycopene (control), 20 mg lycopene from watermelon juice and 20 mg lycopene from tomato juice

There was a significant positive correlation between each pair of total cholesterol and MDA and MDA and FRAP and between HDL-C and MDA and HDL-C and GPX. A significant negative correlation was found between triglycerides and GPX (Table 2).

Table 2

Spearman's Correlation Coefficients between antioxidant tests of malondialdehyde (MDA) ferric reducing ability of plasma (FRAP), and plasma glutathione peroxidase (GPX) and cholesterol measurements.

Variable

MDA

FRAP

GPX

Total cholesterol

0.547**

0.325**

0.003

HDL-C

0.563**

0.059

0.294**

Triglycerides

0.219

0.037

-0.229*

MDA

0.474**

0.180

FRAP

0.474**

0.077

Correlations significant at the 0.05* and 0.01** level.

Because of the correlation between cholesterol concentrations and antioxidant analysis, a preliminary analysis of data was conducted to determine if cholesterol levels impacted antioxidant results. Subjects were separated into two groups based upon baseline concentrations of plasma triglycerides, total cholesterol and LDL-C above or below 200, 180 and 160, respectively. Five subjects, two men and three women, fit the criteria of moderately hypercholesterolemic (Table 3).

Table 3

Separation of subjects by baseline cholesterol levels from a watermelon and tomato juice lycopene intervention study, n = 5 for each group.

Cholesterol Group

Total Cholesterol mg/dl

Triglycerides mg/dl

HDL-Cmg/dl

229.3 ± 4.9

190.9 ± 12.8

59.1 ± 2.9

176.6 ± 2.5

129.7 ± 5.2

46.9 ± 2.1

Data represents mean ± SE

Analyses showed an interaction of cholesterol level × treatment period × treatment factor for MDA and FRAP analysis. Higher MDA and FRAP levels were found in the group having higher cholesterol levels compared to the other group (Table 4). No trend with cholesterol level and glutathione peroxidase was found.

Table 4

Total, triglyceride, high density lipoprotein (HDL-C cholesterol and antioxidant analysis of malondialdehyde (MDA), glutathione peroxidase (GPX) and ferric reducing ability of of plasma (FRAP) after 4 week lycopene depletion and three weeks of intervention with watermelon and tomato juice (20 mg lycopene/day). Subjects were separated into 2 groups based upon cholesterol levels (see Table 3).

Cholesterol Group

Analysis

Depletion

Control

Watermelon

Tomato

Total Cholesterol (mg/dl)

220.9

9.5

223.4

7.9

224.6

8.2

233.6

6.2

Triglycerides (mg/dl)

185.9

16.9

181.7

16.9

198.9

18.3

174.7

15.6

HDL-C (mg/dl)

56.9

5.15

58.65

4.31

58.00

5.96

59.38

4.55

MDA (umol/L)

1.21

0.11

1.12

0.11

1.15

0.12

1.37

0.11

GPX (umol/L)

2728

219

2728

222

2263

169

2574

187

FRAP (umol/L)

831.6

24.9

871.7

26.7

900.9

25.2

861.6

23.4

Total Cholesterol (mg/dl)

182.6

4.2

173.3

3.3

186.1

6.4

173.1

2.8

Triglycerides (mg/dl)

129.4

8.3

128.7

7.6

189.4

4.9

135.4

10.7

HDL-C (mg/dl)

42.5

3.3

43.6

2.8

44.7

4.0

38.3

2.8

MDA (umol/L)

0.53

0.03

0.56

0.04

0.48

0.04

0.54

0.03

GPX (umol/L)

2129

151

2111

154

2292

168

2229

160

FRAP (umol/L)

743.9

33.6

762.9

30.7

780.9

32.4

756.7

36.0

Discussion

We found no improvement in the antioxidant status of healthy middle-aged adults supplemented with two lycopene-containing foods. In previous antioxidant studies, reduced lipid peroxidation was reported in subjects supplemented from one to four weeks with 5 to 45 mg lycopene containing tomato products 15162326. However, in each of these studies, the diet was not controlled. When healthy elderly subjects in a diet controlled study were supplemented with 13.3 mg of tomato lycopene (LycoRed) for 12 weeks, lycopene intervention did not significantly change LDL oxidation, as measured by the rate of conjugated diene production 27.

The reports from lycopene intervention studies that measured FRAP activity are not in agreement. One study reported improvement in FRAP levels of plasma in subjects supplemented with tomato juice and olive oil 28, while two other tomato juice intervention studies reported no improvement in plasma antioxidant levels after lycopene supplementation as measured by Trolox equivalent antioxidant capacity (TEAC), radical trapping antioxidant parameter assay (TRAP), and FRAP 323. Researchers in one study found that the FRAP assay was more accurate when measuring the antioxidant activity of water-soluble antioxidants 23. They thought full expression of the antioxidant activity was not identified from lycopene in this assay since it is a lipophyllic compound. Curiously, both watermelon and tomato contain other water-soluble compounds that are reported to have antioxidant activity that reacts in vitro in the FRAP assay 929. In this study, contribution of these water-soluble compounds in changes in plasma FRAP activity with either food intervention compared to the control was not found.

Unlike a previous report by Fuhrman et al., neither lycopene intervention with watermelon nor tomato affected cholesterol levels 19. Differences in results may have been due to lycopene dosage level. In that study 19 the subjects were supplemented with 60 mg/day for three months, however diet was not controlled.

Fruits and vegetables are excellent sources of antioxidant compounds and the average American consumes only 1.5 and 3.1 servings per day 45. In many of the studies where antioxidant protection with lycopene containing foods was reported, subjects consumed their normal diet that may or may not have met the recommended servings of fruits and vegetables 1323263132. Increasing fruit and vegetable consumption to 12 servings per day compared to 5.8 servings, without the addition of other diet interventions, reduced a biomarker of DNA oxidative damage (8-hydroxydeoxyguanosine) by 32% 33. In a controlled trial where subjects were supplemented with tomato juice but restricted in total fruit and vegetable consumption and exposed to low levels of ozone, researchers found reduced DNA strand breaks compared to placebo controls 34. Because this study controlled for other phytochemical containing fruits and vegetables, the DNA protection was attributed to tomato juice phytochemicals 34.

The positive correlation between total cholesterol and MDA antioxidant analysis has been reported in studies with hypercholesterolemic subjects compared to normocholesterolemic subjects 3536. The MDA assay measures lipid peroxidation products, and a higher level of lipids available to react with peroxidizing agents results in higher MDA values 3637.

The trend correlating higher FRAP with higher cholesterol levels has not been previously reported. The significance of this trend is speculative, since the FRAP assay measures the oxidation and reduction potential of compounds based on the reduction of the ferric to ferrous iron 38, lipid peroxidation products may have contributed to the oxidation/reduction potential of the reaction.

Conclusions

Long-term supplementation studies where diet is controlled will probably be necessary to identify the benefits provided by lycopene. There may be real health benefits associated with lycopene especially since it is stored in various tissues and exhibits strong antioxidant activity in vitro 8103940. Also the body of epidemiological evidence points to the protection provided against cardiovascular disease and some cancers with lycopene containing foods 11124142. Recent cancer intervention studies have reported beneficial effects on prostate cancer from lycopene food supplementation 4344. The health benefits associated with diets providing lycopene are most likely long-term. Therefore, the findings of the present study should not be interpreted as a lack of health benefits from regular consumption of lycopene-rich foods.

The interaction between cholesterol levels and antioxidant values needs more research. Contradictory findings of this study with other ex vivo antioxidant studies may be due to the cholesterol levels of subjects thus warranting further research.

Competing interests

None declared.

Note

Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. All programs and services of the U.S. Department of Agriculture are offered on a nondiscriminatory basis without regard to race, color, national origin, religion, sex, age, marital status, or handicap. The article cited was prepared by a USDA employee as part of his/her official duties. Copyright protection under U.S. copyright law is not available for such works. Accordingly, there is no copyright to transfer. The fact that the private publication in which the article appears is itself copyrighted does not affect the material of the U.S. Government, which can be freely reproduced by the public.

Authors' contributions

JKC: conception and design of the study, drafted the manuscript, BHA: design of study, editing, PLC:design of the study, statistical analysis, PPV: conception of study, editing, RAB: editing, technical assistance, BAC:conception of study, editing. All authors read and approved the final manuscript.

Acknowledgements

Research supported in part by a grant from the National Watermelon Promotion Board, Orlando, FL. Researchers would like to acknowledge the following individuals for their technical assistance: Kari Callicoat, Edralin Lucas and Jarrod King.

Carotenoid Content of U.S. Foods: An Update of the Database Holden AL Eldridge AL Beecher GR Buzzard IM Bhagwat SA Davis CS Douglas LW Gebhardt SE Haytowitz DB Schakel S J Food Comp Anal 1999 12 169 196 10.1006/jfca.1999.0827 Lycopene content differs among red-fleshed watermelon cultivars Perkins-Veazie P Collins JK Pair SD Roberts W J Science of Food and Agric 2001 81 1 5 10.1002/1097-0010(20010101)81:1<1::AID-JSFA819>3.3.CO;2-1 Intestinal absorption of lycopene from different matrices and interactions to other carotenoids, the lipid status, and the antioxidant capacity of human plasma Bohm V Bitsch R Eur J Nutr 1999 38 118 125 10.1007/s003940050052 10443333 Lycopene in tomatoes: chemical and physical properties affected by food processing Shi J Le Maguer M Crit Rev Biotechnol 2000 20 293 334 11192026 Lycopene is more bioavailable from tomato paste than from fresh tomatoes Gartner C Stahl W Sies H Am J Clin Nutr 1997 66 116 122 9209178 Carotenoid bioavailability in humans from tomatoes processed in different ways determined from the carotenoid response in the triglyceride-rich lipoprotein fraction of plasma after a single consumption and in plasma after four days of consumption het Hof KH de Boer BC Tijburg LB Lucius BR Zijp I West CE Hautvast JG Weststrate JA J Nutr 2000 130 1189 1196 10801917 Consumption of watermelon juice increases plasma concentrations of lycopene and beta-carotene in humans Edwards AJ Vinyard BT Wiley ER Brown ED Collins JK Perkins-Veazie P Baker RA Clevidence BA J Nutr 2003 133 1043 1050 12672916 Lycopene as the most efficient biological carotenoid singlet oxygen quencher Di Mascio P Kaiser S Sies H Arch Biochem Biophys 1989 274 532 538 2802626 Antioxidant capacity of lycopene-containing foods Djuric Z Powell LC Int J Food Sci Nutr 2001 52 143 149 11303462 Biological activities of natural and synthetic carotenoids: induction of gap junctional communication and singlet oxygen quenching Stahl W Nicolai S Briviba K Hanusch M Broszeit G Peters M Martin HD Sies H Carcinogenesis 1997 18 89 92 10.1093/carcin/18.1.89 9054593 Serum lycopene concentrations and carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study Rissanen TH Voutilainen S Nyyssonen K Salonen R Kaplan GA Salonen JT Am J Clin Nutr 2003 77 133 138 12499332 Inverse association between carotid intima-media thickness and the antioxidant lycopene in atherosclerosis Gianetti J Pedrinelli R Petrucci R Lazzerini G De Caterina M Bellomo G De Caterina R Am Heart J 2002 143 467 474 10.1067/mhj.2002.120776 11868053 Consumption of vegetables reduces genetic damage in humans: first results of a human intervention trial with carotenoid-rich foods Pool-Zobel BL Bub A Muller H Wollowski I Rechkemmer G Carcinogenesis 1997 18 1847 1850 10.1093/carcin/18.9.1847 9328185 Does tomato consumption effectively increase the resistance of lymphocyte DNA to oxidative damage? Riso P Pinder A Santangelo A Porrini M Am J Clin Nutr 1999 69 712 718 10197573 Effect of low dose lycopene intake on lycopene bioavailability and oxidative stress Rao AV,Shen,H. Nutrition Research 2002 22 1125 1131 10.1016/S0271-5317(02)00430-X Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study Agarwal S Rao AV Lipids 1998 33 981 984 9832077 Dietary supplementation with a natural carotenoid mixture decreases oxidative stress Kiokias S Gordon MH Eur J Clin Nutr 2003 57 1135 1140 10.1038/sj.ejcn.1601655 12947433 Lycopene and cardiovascular disease Arab L Steck S Am J Clin Nutr 2000 71 1691S 1695S 10837319 Hypocholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages Fuhrman B Elis A Aviram M Biochem Biophys Res Commun 1997 233 658 662 10.1006/bbrc.1997.6520 9168909 Native and partially hydrolyzed psyllium have comparable effects on cholesterol metabolism in rats Arjmandi BH Sohn E Juma S Murthy SR Daggy BP J Nutr 1997 127 463 469 9082031 The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay Benzie IF Strain JJ Anal Biochem 1996 239 70 76 10.1006/abio.1996.0292 8660627 Oxidants and antioxidants in long-term haemodialysis patients Drai J Bannier E Chazot C Hurot JM Goedert G Jean G Charra B Laurent G Baltassat P Revol A Farmaco 2001 56 463 465 10.1016/S0014-827X(01)01063-1 11482779 Moderate intervention with carotenoid-rich vegetable products reduces lipid peroxidation in men Bub A Watzl B Abrahamse L Delincee H Adam S Wever J Muller H Rechkemmer G J Nutr 2000 130 2200 2206 10958813 Varying dietary fat type of reduced-fat diets has little effect on the susceptibility of LDL to oxidative modification in moderately hypercholesterolemic subjects Schwab US Vogel S Lammi-Keefe CJ Ordovas JM Schaefer EJ Li Z Ausman LM Gualtieri L Goldin BR Furr HC Lichtenstein AH J Nutr 1998 128 1703 1709 9772139 Age, menopause and hormone replacement therapy influences on cardiovascular risk factors in a cohort of middle-aged Chilean women Castelo-Branco C Blumel JE Roncagliolo ME Haya J Bolf D Binfa L Tacla X Colodron M Maturitas 2003 45 205 212 10.1016/S0378-5122(03)00140-3 12818466 Effects of tomato juice consumption on plasma and lipoprotein carotenoid concentrations and the susceptibility of low density lipoprotein to oxidative modification Maruyama C Imamura K Oshima S Suzukawa M Egami S Tonomoto M Baba N Harada M Ayaori M Inakuma T Ishikawa T J Nutr Sci Vitaminol (Tokyo) 2001 47 213 221 11575576 Lipoprotein carotenoid profiles and the susceptibility of low density lipoprotein to oxidative modification in healthy elderly volunteers Carroll YL Corridan BM Morrissey PA Eur J Clin Nutr 2000 54 500 507 10.1038/sj.ejcn.1601046 10878653 Consumption of tomato products with olive oil but not sunflower oil increases the antioxidant activity of plasma Lee A Thurnham DI Chopra M Free Radic Biol Med 2000 29 1051 1055 10.1016/S0891-5849(00)00440-8 11084294 Processing effects on lycopene content and antioxidant activity of tomatoes Takeoka GR Dao L Flessa S Gillespie DM Jewell WT Huebner B Bertow D Ebeler SE J Agric Food Chem 2001 49 3713 3717 10.1021/jf0102721 11513653 Diet quality index: capturing a multidimensional behavior Patterson RE Haines PS Popkin BM J Am Diet Assoc 1994 94 57 64 10.1016/0002-8223(94)92042-7 8270756 Recovery of human lymphocytes from oxidative DNA damage; the apparent enhancement of DNA repair by carotenoids is probably simply an antioxidant effect Torbergsen AC Collins AR Eur J Nutr 2000 39 80 85 10.1007/s003940050006 10918989 Mechanisms by which vegetable consumption reduces genetic damage in humans Pool-Zobel BL Bub A Liegibel UM Treptow-van Lishaut S Rechkemmer G Cancer Epidemiol Biomarkers Prev 1998 7 891 899 9796634 Effect of increased vegetable and fruit consumption on markers of oxidative cellular damage Thompson HJ Heimendinger J Haegele A Sedlacek SM Gillette C O'Neill C Wolfe P Conry C Carcinogenesis 1999 20 2261 2266 10.1093/carcin/20.12.2261 10590217 Effect of antioxidant supplementation on ozone-induced lung injury in human subjects Samet JM Hatch GE Horstman D Steck-Scott S Arab L Bromberg PA Levine M McDonnell WF Devlin RB Am J Respir Crit Care Med 2001 164 819 825 11549539 Reduced susceptibility of low density lipoprotein to lipid peroxidation after cholestyramine treatment in heterozygous familial hypercholesterolemic children Hussein O Frydman G Frim H Aviram M Pathophysiology 2001 8 21 28 10.1016/S0928-4680(01)00061-X 11476969 Levels of thiobarbituric acid-reactive substance in plasma from coronary artery disease patients Sakuma N Hibino T Sato T Ohte N Akita S Tamai N Sasai K Yoshimata T Fujinami T Clin Biochem 1997 30 505 507 10.1016/S0009-9120(97)00050-7 9316747 Lower concentrations of carotenoids in the critically ill patient are related to a systemic inflammatory response and increased lipid peroxidation Quasim T McMillan DC Talwar D Sattar N O'Reilly DS Kinsella J Clin Nutr 2003 22 459 462 10.1016/S0261-5614(03)00044-X 14512033 Intakes of Antioxidants in Coffee, Wine, and Vegetables Are Correlated with Plasma Carotenoids in Humans Svilaas A Sakhi AK Andersen LF Svilaas T Strom EC Jacobs D.R.,Jr. Ose L Blomhoff R J Nutr 2004 134 562 567 14988447 Absorption and transport of carotenoids Erdman J.W.,Jr. Bierer TL Gugger ET Ann N Y Acad Sci 1993 691 76 85 8129321 Absorption, metabolism, and transport of carotenoids Parker RS FASEB J 1996 10 542 551 8621054 A prospective study of tomato products, lycopene, and prostate cancer risk Giovannucci E Rimm EB Liu Y Stampfer MJ Willett WC J Natl Cancer Inst 2002 94 391 398 10.1093/jnci/94.5.391 11880478 Dietary carotenoids and risk of gastric cancer: a case-control study in Uruguay De Stefani E Boffetta P Brennan P Deneo-Pellegrini H Carzoglio JC Ronco A Mendilaharsu M Eur J Cancer Prev 2000 9 329 334 10.1097/00008469-200010000-00007 11075886 Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy Kucuk O Sarkar FH Sakr W Djuric Z Pollak MN Khachik F Li YW Banerjee M Grignon D Bertram JS Crissman JD Pontes EJ Wood D.P.Jr. Cancer Epidemiol Biomarkers Prev 2001 10 861 868 11489752 Tomato sauce supplementation and prostate cancer: lycopene accumulation and modulation of biomarkers of carcinogenesis Bowen P Chen L Stacewicz-Sapuntzakis M Duncan C Sharifi R Ghosh L Kim HS Christov-Tzelkov K van Breemen R Exp Biol Med (Maywood ) 2002 227 886 893 12424330 U.S. Dept. of Agriculture, Agriculture Research Service 2000 Servings Intakes by U.S. Children and Adults: 1994-1996, 1998. Online. ARS Community Nutrition Research Group web site available at http://http//www.barc.usda.gov/bhnrc/cnrg, accessed Sept. 23, 2004.